Department of Orthopaedic Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
J Arthroplasty. 2021 Jul;36(7S):S179-S183. doi: 10.1016/j.arth.2021.02.023. Epub 2021 Feb 12.
Patients with mood disorders undergoing total joint arthroplasty (TJA) are at increased risk for poor outcomes. This study seeks to examine the effect of anxiety disorders on pain following TJA and evaluate if anxiety disorders are a modifiable risk factor.
Between March 2019 and July 2020, 319 TJA patients had preoperative anxiety screening using the Generalized Anxiety Disorder 2-item screening tool (GAD-2) and 6-week postoperative Pain Catastrophizing Scale scores. Patients were organized into 4 cohorts based on preoperative selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor (SSRI/SNRI) use and GAD-2 scores: Group 1: no SSRI/SNRI use and GAD-2 score <3 (control patients); Group 2: SSRI/SNRI use and GAD-2 score <3 (appropriately treated GAD patients); Group 3: no SSRI/SNRI use and GAD-2 score ≥3 (untreated GAD patients); and Group 4: SSRI/SNRI use and GAD-2 score ≥3 (poorly treated GAD patients). The cohorts underwent multivariate linear regression analysis and equivalence testing.
Patients with preoperative GAD-2 scores ≥3 had worse postoperative pain with significantly higher average 6-week postoperative Pain Catastrophizing Scale score than patients with GAD-2 scores <3 (9.90 vs 5.19, P < .001). Patients with appropriately treated GAD and the control group had statistically equivalent postoperative pain, while patients with poorly treated or untreated GAD had worse postoperative pain.
Preoperative GAD is a risk factor for poor postoperative pain control but is a modifiable risk factor when patients are appropriately treated. Screening for preoperative GAD with GAD-2 and referral for treatment may improve patient outcomes and reduce opioid consumption following TJA.
患有心境障碍的接受全关节置换术(TJA)的患者发生不良预后的风险增加。本研究旨在探讨焦虑症对 TJA 后疼痛的影响,并评估焦虑症是否为可改变的危险因素。
在 2019 年 3 月至 2020 年 7 月期间,使用广泛性焦虑障碍 2 项筛查工具(GAD-2)对 319 例 TJA 患者进行术前焦虑筛查,并对术后 6 周的疼痛灾难化量表评分进行评估。根据患者术前选择性 5-羟色胺再摄取抑制剂/5-羟色胺去甲肾上腺素再摄取抑制剂(SSRIs/SNRIs)的使用情况和 GAD-2 评分将患者分为 4 组:组 1:未使用 SSRIs/SNRIs 且 GAD-2 评分<3(对照组);组 2:使用 SSRIs/SNRIs 且 GAD-2 评分<3(适当治疗的 GAD 患者);组 3:未使用 SSRIs/SNRIs 且 GAD-2 评分≥3(未治疗的 GAD 患者);组 4:使用 SSRIs/SNRIs 且 GAD-2 评分≥3(治疗不当的 GAD 患者)。对各组进行多变量线性回归分析和等效性检验。
术前 GAD-2 评分≥3 的患者术后疼痛更严重,术后 6 周的平均疼痛灾难化量表评分显著高于 GAD-2 评分<3 的患者(9.90 比 5.19,P<.001)。适当治疗 GAD 的患者和对照组的术后疼痛相当,而治疗不当或未治疗的 GAD 的患者的术后疼痛更严重。
术前 GAD 是术后疼痛控制不良的危险因素,但在患者得到适当治疗时,GAD 是可改变的危险因素。使用 GAD-2 进行术前 GAD 筛查并进行治疗转诊可能会改善患者的预后并减少 TJA 后的阿片类药物使用。